home / stock / fwbi / fwbi news


FWBI News and Press, First Wave BioPharma Inc. From 02/13/24

Stock Information

Company Name: First Wave BioPharma Inc.
Stock Symbol: FWBI
Market: NASDAQ

Menu

FWBI FWBI Quote FWBI Short FWBI News FWBI Articles FWBI Message Board
Get FWBI Alerts

News, Short Squeeze, Breakout and More Instantly...

FWBI - First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024

BOCA RATON, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointe...

FWBI - MARA, CLSK and AU are among pre market gainers

2024-01-24 08:35:25 ET Nxu  ( NXU ) +37% Showcasing Innovation and Leadership in EV Charging Technology. SciSparc  ( SPRC ) +50% announces $20M standby equity purchase agreement. Kura Oncology  ( KURA ) +35% announces oversubscribed $150 mi...

FWBI - First Wave BioPharma to Present at the DealFlow MicroCap Conference

BOCA RATON, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointe...

FWBI - First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico

BOCA RATON, Fla., Jan. 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointe...

FWBI - First Wave BioPharma files to sell 1.76M for holders

2024-01-08 17:27:13 ET More on First Wave BioPharma First Wave expecting "significant" investments if ImmunogenX deal closes First Wave Biopharma announces exercise of warrants, issuance of new warrants in private placement for $4.8M gross proceeds priced Seeking Alp...

FWBI - First Wave expecting "significant" investments if ImmunogenX deal closes

2024-01-04 13:44:51 ET More on First Wave BioPharma First Wave Biopharma announces exercise of warrants, issuance of new warrants in private placement for $4.8M gross proceeds priced First Wave BioPharma surges on plans to sell niclosamide program Seeking Alphaȁ...

FWBI - NEXI, MTC and MOLN among pre-market losers

2024-01-04 08:31:40 ET Losers: Mobileye Global ( MBLY ) -27% releases preliminary FY2023 financial results and initial 2024 outlook . Opko Health OPK -16% commences private offering of convertible senior notes . Neximmune ( NEXI ) -16% . Mmtec (...

FWBI - First Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024

BOCA RATON, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointe...

FWBI - TENX, TAOP and AISP among mid-day movers

2024-01-03 12:43:51 ET More on Mid-day movers & stocks. Tenax falls as rally driven by IND clearance cools Tenax stock jumps after FDA greenlights studies for hypertension candidate Financial information for Airship AI Holdings, Inc. Financial information...

FWBI - 24/7 Market News Lunch Break 3 Jan 2024

2024-01-03 12:20:37 ET DENVER, Colo., Jan. 3, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Sidus Space Inc (NASDAQ: SIDU), ABVC Biopharma Inc (NASDAQ: ABVC), Dyne Therapeutics Inc (NASDAQ: DYN),...

Previous 10 Next 10